Iran's War Has Ignited a Defense CapEx Super-Cycle — Inside the Factory Buildouts and Production Ramps at LMT, RTX, and NOC That Wall Street Still Underestimates
Since hostilities with Iran escalated into a full-spectrum conflict, the conversation around U.S. defense stocks has centered on demand — backlog growth, order intake, Foreign Military Sales surges. That story is real, but it obscures a quieter, arguably more consequential transformation happening on the supply side. Lockheed Martin, Raytheon (RTX), and Northrop Grumman are not simply booking more orders. They are undertaking the largest coordinated capital-expenditure cycle the American defense-industrial base has seen since the Reagan buildup of the 1980s. And the financial implications of that factory-floor revolution are only beginning to ripple through consensus estimates.
★ Related Stocks & ETFs at a Glance
| Ticker | Company / Fund | Sector | Iran-Conflict Relevance | Bias |
|---|---|---|---|---|
| LMT | Lockheed Martin | Aerospace & Defense | F-35 production ramp, JASSM-ER line expansion, PAC-3 capacity doubling | ▲ Bullish |
| RTX | RTX Corporation | Aerospace & Defense | Patriot system demand, SM-6 production scaling, Pratt & Whitney military engine surge | ▲ Bullish |
| NOC | Northrop Grumman | Aerospace & Defense | B-21 Raider ramp, IBCS integration, Sentinel ICBM program acceleration | ▲ Bullish |
| GD | General Dynamics | Defense / Marine | 155mm artillery shell production tripling, submarine industrial base expansion | ▲ Bullish |
| HII | Huntington Ingalls | Shipbuilding | Carrier strike group maintenance surge, destroyer production backlog | ▲ Bullish |
| KTOS | Kratos Defense | Unmanned Systems | Attritable drone production, Valkyrie program, low-cost cruise missile defense targets | ▲ Bullish |
| AXON | Axon Enterprise | Defense Tech | Sensor fusion, battlefield awareness — tangential but growing DoD footprint | ◆ Neutral |
| ITA | iShares U.S. Aerospace & Defense ETF | ETF | Broad defense exposure, LMT/RTX/NOC top holdings | ▲ Bullish |
| DFEN | Direxion Daily Aero & Defense Bull 3X | Leveraged ETF | 3x leveraged defense play — high risk, high reward on sector momentum | ▲ Bullish (High Vol) |
| XAR | SPDR S&P Aerospace & Defense ETF | ETF | Equal-weighted, better mid-cap defense exposure including KTOS, L3Harris | ▲ Bullish |
| XLE | Energy Select Sector SPDR | ETF | Oil price proxy; energy remains correlated to Iran escalation trajectory | ▲ Bullish |
| USO | United States Oil Fund | Commodity ETF | Direct crude exposure — Hormuz risk premium embedded | ◆ Neutral |
The Supply-Side Story Nobody's Modeling Correctly
Walk into any sell-side defense analyst's model today and you'll find neatly rising revenue lines justified by record backlogs. That part is straightforward. What most models miss is how the current CapEx cycle alters the margin structure and earnings power of these businesses over the next three to five years.
Here's the core dynamic: for more than a decade following sequestration, the Big Three defense primes operated in harvest mode. Capital expenditures ran at roughly 2–3% of revenue. Factories were optimized for efficiency on legacy programs at steady-state production rates. Margins were defended through cost-cutting, share buybacks, and disciplined working capital management. The Street rewarded this with a "defense-as-utility" valuation framework — 15–17x forward earnings, a fat dividend, and minimal excitement.
The Iran conflict has shattered that equilibrium. What we're witnessing now is a violent regime change — not in Tehran, but in how defense companies allocate capital.
Inside the Factory Buildouts: LMT, RTX, NOC
Lockheed Martin (LMT): Three Simultaneous Production Ramps
Lockheed is executing what management has called the most ambitious production expansion in company history, across three critical programs simultaneously:
- F-35 production: The long-delayed push to 156+ jets per year is finally being resourced with new tooling, a second final-assembly pulse line, and expanded supplier commitments. CapEx at the Fort Worth facility alone is running at roughly $800 million annually — triple the 2023 rate.
- JASSM-ER / LRASM production: Precision standoff munitions have been consumed at rates no one in the Pentagon planned for. Lockheed broke ground on a new missile integration facility in Troy, Alabama in late 2025, with initial operating capability targeted for Q3 2026. This line is designed to double monthly JASSM output within 18 months.
- PAC-3 MSE capacity: The Patriot interceptor that has become synonymous with Iran-theater air defense is seeing its production line expanded at the Camden, Arkansas facility. Lockheed disclosed on its Q1 2026 earnings call that PAC-3 unit deliveries are expected to increase 70% year-over-year by late 2027.
The financial takeaway: Lockheed's CapEx-to-revenue ratio has jumped from 2.4% in 2023 to an estimated 4.1% in 2026, with management guiding toward sustained elevated spending through at least 2029. That's a lot of upfront cash going into the ground. But here's what matters — these aren't speculative bets. They are government-funded or government-backstopped capacity expansions, many with cost-plus or incentive-fee structures that virtually guarantee returns on invested capital north of 15%.
RTX Corporation: The Integration Dividend Meets Wartime Demand
RTX's story is distinct because the company is simultaneously completing its post-merger integration (Raytheon + Collins Aerospace + Pratt & Whitney) while scaling production on its most in-demand platforms:
- Patriot system production: Full Patriot fire units — not just interceptors — are backordered for years. RTX is investing over $1 billion in expanding its Andover, Massachusetts and Tucson, Arizona missile facilities. The Patriot system has become a de facto currency of allied security commitments, and every new U.S. deployment to the Gulf region pulls forward allied procurement.
- SM-6 multi-mission missile: The Navy's Swiss Army knife of air defense, anti-ship, and land-attack is seeing production targets revised upward repeatedly. RTX's new Block IB variant, with extended range and improved terminal guidance, is being fast-tracked specifically because of Iranian anti-ship ballistic missile threats.
- Pratt & Whitney military engines: The F135 engine powering every F-35 in existence is seeing aftermarket and overhaul demand spike as operational tempo in the Gulf theater pushes engine cycles faster than peacetime models assumed. Pratt is expanding its military engine MRO capacity — a high-margin, recurring revenue stream the market hasn't fully valued.
RTX's CapEx has moved from roughly $2.6 billion in FY2024 to a guided $3.4 billion in FY2026. The crucial detail: an increasing share of that spend is going into capacity for programs with multi-decade production tails. These factories aren't being built for a two-year war. They're being built for a generation of elevated defense spending.
Northrop Grumman (NOC): The Stealth-and-Deterrence Franchise
Northrop's expansion is the most classified and therefore the most under-appreciated by the market:
- B-21 Raider production: The next-generation stealth bomber is transitioning from low-rate initial production to a planned ramp toward 100+ aircraft. Northrop's Palmdale facility expansion is one of the largest defense construction projects in the country, yet its details remain largely behind the security classification wall — which means most analysts model it conservatively.
- IBCS (Integrated Battle Command System): The Army's network-centric air defense command system has gone from a troubled development program to the connective tissue linking Patriot, THAAD, and emerging directed-energy weapons in a theater where integrated air and missile defense is existential. Production and fielding are accelerating.
- Sentinel ICBM: While not directly Iran-related, the broader threat environment has made the Sentinel nuclear modernization program politically untouchable, ensuring Northrop's largest single program remains fully funded regardless of election outcomes.
Northrop's capital intensity is rising more modestly in percentage terms (given the B-21's classified funding flows), but its book-to-bill ratio has exceeded 1.3x for five consecutive quarters — a signal that order intake is outpacing even the expanded revenue capacity the company is building.
The Earnings Math Wall Street Keeps Getting Wrong
Here's where the investment thesis crystallizes. The standard analyst response to rising CapEx is caution: "They're spending more cash, free cash flow will compress, wait for the returns to materialize." And in a normal industrial context, that skepticism is warranted.
But defense CapEx in a wartime environment operates under fundamentally different economics:
- Demand visibility is unprecedented. These companies aren't building factories hoping orders will come. The orders are already booked. Combined backlogs across LMT, RTX, and NOC exceeded $470 billion entering Q2 2026 — representing roughly 3.5 years of revenue at current run rates. In normal times, 2.0–2.5x is considered healthy.
- Government co-investment reduces risk. A significant portion of facility expansions are partially or fully funded through Department of Defense industrial base investments, NATO Security Investment Programme allocations, or allied government co-production agreements. The companies' net CapEx burden is substantially lower than headline numbers suggest.
- Production scaling drives margin expansion. Defense programs follow well-documented learning curves — typically an 85–90% curve, meaning every doubling of cumulative production reduces per-unit costs by 10–15%. As production rates ramp on programs like PAC-3, JASSM, and SM-6, margins on those programs expand even if contract pricing remains stable.
- Mix shift toward higher-margin munitions and services. The product mix is shifting away from low-margin platform development toward higher-margin production and sustainment. RTX's missile segment, for example, typically operates at 200–400 basis points higher margins than its system integration business.
The net effect: consensus EPS estimates for FY2027 and FY2028 across all three primes are, in our assessment, 10–15% too low. The Street is modeling the revenue growth correctly but applying historical margin assumptions that don't account for the production-scaling dynamics described above.
What Comes Next: Three Scenarios for the Defense CapEx Cycle
Scenario 1: Sustained Conflict (Base Case, ~50% probability)
The Iran theater remains active through 2027–2028, with periodic escalations and de-escalations but no comprehensive ceasefire. U.S. and allied defense spending continues its upward trajectory. In this environment, defense primes continue ramping production, backlog grows, and the earnings revision cycle persists. LMT, RTX, and NOC likely trade at 20–22x forward earnings — a permanent re-rating from the pre-conflict 16–18x range, reflecting higher growth and better visibility.
Scenario 2: Negotiated De-Escalation (~30% probability)
A diplomatic settlement reduces active hostilities, but the strategic recalibration of Western defense spending proves irreversible. History is instructive here: after the Korean War, U.S. defense spending never returned to pre-1950 levels. After 9/11, it never returned to 1990s levels. The Iran conflict has established a new floor for global defense investment. In this scenario, production ramps slow modestly but don't reverse. Defense stocks may see a 10–15% pullback on ceasefire headlines before stabilizing at higher valuations than pre-conflict levels. The factory buildouts already under construction don't get unwound.
Scenario 3: Broader Regional Escalation (~20% probability)
The conflict expands to involve direct confrontation with Iranian proxies across multiple theaters, potential disruption of critical waterways, or conflict spillover into the broader Middle East. In this scenario, defense spending enters a wartime mobilization paradigm. Emergency supplemental appropriations bypass normal budget cycles. Production rates are pushed to maximum capacity. Defense stocks surge, potentially overshooting fair value before eventually correcting. This is the tail-risk scenario where DFEN and leveraged defense exposure would generate outsized returns — but also the scenario with the highest macro risk to overall portfolio performance.
The Hidden Beneficiaries: Second- and Third-Tier Suppliers
When Lockheed doubles JASSM production, it doesn't just benefit Lockheed. The entire supply chain — from specialty metals producers to advanced electronics firms to precision machining companies — sees order flow increase. Investors focused exclusively on the Big Three primes may be missing compelling opportunities among suppliers like:
- Mercury Systems (MRCY) — defense electronics and processing subsystems
- Curtiss-Wright (CW) — defense electronics and engineered products
- Kratos Defense (KTOS) — unmanned systems and missile defense targets, with leverage to the attritable drone concept that the Iran theater is validating daily
- BWX Technologies (BWXT) — nuclear propulsion and components for the naval expansion
The XAR ETF (SPDR S&P Aerospace & Defense) offers broader, equal-weighted exposure to this supplier ecosystem compared to the market-cap-weighted ITA, which is top-heavy in Boeing and the mega-cap primes.
Investment Considerations: Valuation, Timing, and Risk
For investors evaluating defense sector exposure in the current environment, several factors warrant careful consideration:
Valuation is elevated but potentially justified. LMT, RTX, and NOC are all trading above their 5-year average forward P/E multiples. The question is whether this reflects a temporary war premium or a permanent re-rating. The evidence — record backlogs, multi-year production ramps, structurally higher global defense budgets — suggests the latter, though markets can always overshoot.
The CapEx cycle creates a near-term free cash flow headwind. Investors accustomed to defense stocks as cash-flow machines should expect FCF conversion to lag earnings growth for the next 12–18 months as CapEx peaks. This is a feature, not a bug — but it requires patience and conviction that the invested capital will generate returns on the back end.
Political risk is real but overestimated. Defense spending has historically been one of the most bipartisan areas of U.S. fiscal policy. The Iran conflict has, if anything, widened the political consensus around defense investment. The greater political risk lies not in spending cuts but in potential regulatory actions around pricing and profitability — a tail risk worth monitoring but not one currently reflected in legislative momentum.
Correlation with broader equities is declining. Defense stocks have exhibited falling beta to the S&P 500 during this conflict period, behaving more like a distinct asset class than a cyclical sector. This diversification benefit is itself valuable in a portfolio context, particularly for investors seeking returns uncorrelated with the technology-driven equity market.
The Bottom Line
The Iran conflict has catalyzed something far more durable than a temporary defense-stock rally. It has triggered a structural reinvestment cycle across the American defense-industrial base — billions of dollars flowing into new factories, production lines, and workforce expansion that will generate returns for years regardless of how the geopolitical situation evolves.
LMT, RTX, and NOC are not simply riding a wartime sentiment wave. They are fundamentally repositioning their businesses for a world in which defense spending is structurally higher, production volumes are structurally larger, and the margin benefits of scale are just beginning to compound through their income statements.
The market has noticed the demand story. It hasn't yet fully priced the supply-side transformation.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always do your own research before making investment decisions. Defense stocks carry unique risks including government budget dependency, program cancellation risk, and regulatory exposure. Past performance does not guarantee future results.
댓글
댓글 쓰기